Medical disclaimer
Last updated July 2026.
Key points
- Everything here is educational. It is not medical advice and does not replace a licensed clinician.
- Reading this site does not create a clinician–patient relationship with anyone.
- Talk to a licensed prescriber before you start, stop, or change any medication or dose — microdosing included.
- Compounded and microdosed GLP-1 are not FDA-approved and are not the same as brand-name Wegovy, Ozempic, or Zepbound.
- If you have a medical emergency, call 911 or your local emergency number right now.
Educational only — not medical advice
Low Dose GLP-1 publishes evidence summaries, dose-response explainers, and comparisons about GLP-1 receptor agonists such as semaglutide and tirzepatide. All of it is written to help you understand the topic. None of it is medical advice, a diagnosis, or a treatment plan, and it is not a substitute for a consultation with a clinician who knows your history. Please do not use this site to self-diagnose or to decide, on your own, how to use a prescription medication.
No clinician–patient relationship
Reading these pages, using our tools, or emailing us does not make you our patient and does not create any clinician–patient relationship. We do not examine you, order tests, prescribe, or manage your care. A treating clinician who can review your full medical picture is the only person able to advise you about your own situation.
Talk to a clinician before you change anything
Please speak with a licensed healthcare professional before you start, stop, or change any medication — and before you change a dose, including microdosing or titration. GLP-1 medicines interact with other drugs and conditions, carry real contraindications and side effects, and are not right for everyone. Bring your questions to your own prescriber and follow their guidance over anything you read here.
Microdosed and compounded GLP-1: extra caution
Much of what you will read here concerns low-dose or microdosed use of GLP-1 medications, so a few things are worth stating plainly. Compounded GLP-1 products are not FDA-approved and have not gone through the safety, effectiveness, and quality review that approved drugs receive. Microdosing is not an approved dosing schedule, and a compounded product can differ from brand-name Wegovy, Ozempic, or Zepbound in concentration, formulation, and purity.
Because of that, every dosing decision — whether to use a compounded product at all, and at what dose — rests with a licensed prescriber who is responsible for your care. Nothing on this site should be read as a recommendation to microdose, to use a compounded product, or to follow any specific dose or schedule.
Results vary from person to person
Any outcomes, timelines, or benefits described here reflect research findings or general patterns, not a promise of what will happen for you. Response to GLP-1 medications differs widely depending on your biology, dose, other conditions, and many factors outside anyone's control. Your experience may be different.
Providers and third-party information
When we describe a clinic, telehealth service, or product, we are sharing information — not endorsing it and not vouching that it is safe or right for you. We do not control these companies and cannot guarantee their programs, pricing, or care. Verify anything important directly with the provider and with your own clinician before you act on it.
Accuracy is not guaranteed
We work hard to keep this site accurate and to cite primary research and official labeling, but medicine moves quickly and details change. We cannot guarantee that everything here is complete, current, or free of error. If something is time-sensitive, confirm it against the original source.
In an emergency
This site cannot help in an emergency. If you think you are having a medical emergency, call 911 (or your local emergency number) or go to the nearest emergency room immediately. Do not delay care because of anything you read here.